GeneDock
PrivateLast Round
Series B
Jul 12, 2018
Total Funding Raised
$7.41M
Company Overview
GeneDock operates in AI, Data & Cloud Infrastructure and is based in Beijing. Its latest recorded funding round was a Series B round in July 2018.
GeneDock is a biotechnology software company that provides cloud-based platforms for genetic data storage, analysis, and collaboration.
Sector
AI, Data & Cloud Infrastructure
Verticals
Cloud Infrastructure, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GeneDock Comparables
Compare GeneDock with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai Majorbio Bio-pharm Technology Co., Ltd. | 76% | |
| Lifebit | 76% | |
| BGI Group | 72% |
For institutional investors. Book with your work email.
GeneDock Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 12, 2018 | ||||
| Series A Extension | Jan 20, 2017 | ||||
| Series A | Aug 20, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GeneDock Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Legend Star | Series A Extension |
| MPC | Series A |
| Frog Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 11, 2024
Monthly visitors grew 373% MoM, from 139 to 658.
- Jul 12, 2018
$7.4M round with BGI Group and Frog Capital.
For institutional investors. Book with your work email.
GeneDock Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GeneDock's valuation, stock price, and market status.
Is GeneDock a public or private company?
GeneDock is a private company.
What is the current stock price of GeneDock?
GeneDock is a private company, so its shares have no public market price. Caplight tracks GeneDock's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GeneDock worth (valuation)?
Valuation information for GeneDock is not publicly available.
Can I buy GeneDock stock?
GeneDock shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GeneDock's last funding round?
GeneDock's most recent funding round was Series B on July 12, 2018.
Who are the main investors in GeneDock?
Key investors in GeneDock include MPC.
Will GeneDock IPO soon?
No public IPO plans have been announced for GeneDock.
How can I track GeneDock secondary market activity?
Caplight tracks bids, offers, and trades in GeneDock's shares on secondary markets.